关注
Reginald van der Kwast
Reginald van der Kwast
Institute of Pharmacology and Toxicology, Technical University of Munich (TUM), 80802, Munich
在 tum.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
MicroRNA-411 and Its 5′-IsomiR have distinct targets and functions and are differentially regulated in the vasculature under ischemia
RVCT van der Kwast, T Woudenberg, PHA Quax, AY Nossent
Molecular Therapy 28 (1), 157-170, 2020
692020
Adenosine-to-inosine editing of microRNA-487b alters target gene selection after ischemia and promotes neovascularization
RVCT van der Kwast, E van Ingen, L Parma, HAB Peters, PHA Quax, ...
Circulation research 122 (3), 444-456, 2018
662018
Adenosine-to-inosine editing of vasoactive microRNAs alters their targetome and function in ischemia
RVCT van der Kwast, L Parma, ML van der Bent, E van Ingen, F Baganha, ...
Molecular Therapy-Nucleic Acids 21, 932-953, 2020
442020
An emerging role for isomiRs and the microRNA epitranscriptome in neovascularization
RVCT van der Kwast, PHA Quax, AY Nossent
Cells 9 (1), 61, 2019
362019
Genetic associations and regulation of expression indicate an independent role for 14q32 snoRNAs in human cardiovascular disease
KEJ Håkansson, EAC Goossens, S Trompet, E Van Ingen, MR De Vries, ...
Cardiovascular research 115 (10), 1519-1532, 2019
352019
N-6-Methyladenosine in vasoactive microRNAs during hypoxia; a novel role for METTL4
DAL van den Homberg, RVCT van der Kwast, PHA Quax, AY Nossent
International journal of molecular sciences 23 (3), 1057, 2022
262022
Stable In Vivo Transgene Expression in Endothelial Cells with Helper-Dependent Adenovirus: Roles of Promoter and Interleukin-10
N Dronadula, BK Wacker, R Van Der Kwast, J Zhang, DA Dichek
Human gene therapy 28 (3), 255-270, 2017
162017
系统目前无法执行此操作,请稍后再试。
文章 1–7